Compare ASMB & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | RYAM |
|---|---|---|
| Founded | 2005 | 1926 |
| Country | United States | United States |
| Employees | N/A | 2325 |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 580.4M |
| IPO Year | 2010 | 2014 |
| Metric | ASMB | RYAM |
|---|---|---|
| Price | $35.44 | $8.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $44.20 | $14.00 |
| AVG Volume (30 Days) | 289.7K | ★ 701.1K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,466,397,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $638.39 | $8.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.23 | $5.38 |
| 52 Week High | $39.71 | $11.85 |
| Indicator | ASMB | RYAM |
|---|---|---|
| Relative Strength Index (RSI) | 62.24 | 47.65 |
| Support Level | $32.57 | $8.18 |
| Resistance Level | $37.00 | $8.82 |
| Average True Range (ATR) | 1.56 | 0.30 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 65.20 | 23.50 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.